Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Relaxivity and toxicological properties of manganese oxide nanoparticles for MRI applications.

Hsu BYW, Kirby G, Tan A, Seifalian AM, Li X, Wang J.

RSC Adv. 2019 May 20;6(51):45462-45474. doi: 10.1039/C6RA04421B. Epub 2016 May 10.

2.

Coating Techniques and Release Kinetics of Drug-Eluting Stents.

Livingston M, Tan A.

J Med Device. 2019 May 4;10(1). doi: 10.1115/1.4031718. Epub 2015 Nov 5.

3.

Carbon nanotube bottles for incorporation, release and enhanced cytotoxic effect of cisplatin.

Li J, Yap SQ, Yoong SL, Nayak TR, Chandra GW, Ang WH, Panczyk T, Ramaprabhu S, Vashist SK, Sheu FS, Tan A, Pastorin G.

Carbon N Y. 2019 May 2;50(4):1625-1634. doi: 10.1016/j.carbon.2011.11.043. Epub 2011 Dec 2.

4.

Parental concern of feeding difficulty predicts poor growth status in their child.

Lee WS, Tee CW, Tan AG, Wong SY, Chew KS, Cheang HK, Lim T, Lum LC, Aw MM.

Pediatr Neonatol. 2019 Apr 13. pii: S1875-9572(18)30549-7. doi: 10.1016/j.pedneo.2019.04.004. [Epub ahead of print]

5.

Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade.

Tan AC, McCrary JM, Park SB, Trinh T, Goldstein D.

Support Care Cancer. 2019 Apr 10. doi: 10.1007/s00520-019-04781-6. [Epub ahead of print]

PMID:
30972648
6.

Third generation EGFR TKI landscape for metastatic EGFR mutant non-small cell lung cancer (NSCLC).

Tan AC, Teh YL, Lai GGY, Tan DSW.

Expert Rev Anticancer Ther. 2019 Jun;19(6):431-435. doi: 10.1080/14737140.2019.1604228. Epub 2019 Apr 14. No abstract available.

PMID:
30950666
7.

New drug developments in metastatic gastric cancer.

Tan AC, Chan DL, Faisal W, Pavlakis N.

Therap Adv Gastroenterol. 2018 Nov 14;11:1756284818808072. doi: 10.1177/1756284818808072. eCollection 2018. Review.

8.

Characteristics and outcomes of oncology unit patients requiring admission to an Australian intensive care unit.

Tan AC, Jacques SK, Oatley M, Guminski AD.

Intern Med J. 2019 Jun;49(6):734-739. doi: 10.1111/imj.14160.

PMID:
30411448
9.

Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder.

Tan A, Costi S, Morris LS, Van Dam NT, Kautz M, Whitton AE, Friedman AK, Collins KA, Ahle G, Chadha N, Do B, Pizzagalli DA, Iosifescu DV, Nestler EJ, Han MH, Murrough JW.

Mol Psychiatry. 2018 Nov 1. doi: 10.1038/s41380-018-0283-2. [Epub ahead of print]

10.

General practitioners (GPs) and end-of-life care: a qualitative study of Australian GPs and specialist palliative care clinicians.

Rhee JJ, Teo PCK, Mitchell GK, Senior HE, Tan AJH, Clayton JM.

BMJ Support Palliat Care. 2018 Nov 1. pii: bmjspcare-2018-001531. doi: 10.1136/bmjspcare-2018-001531. [Epub ahead of print]

PMID:
30385501
11.

Volumetric Multispectral Optoacoustic Tomography for 3-Dimensional Reconstruction of Skin Tumors: A Further Evaluation with Histopathologic Correlation.

Chuah SY, Attia ABE, Ho CJH, Li X, Lee JS, Tan MWP, Yong AA, Tan AWM, Razansky D, Olivo M, Thng STG.

J Invest Dermatol. 2019 Feb;139(2):481-485. doi: 10.1016/j.jid.2018.08.014. Epub 2018 Sep 15. No abstract available.

PMID:
30227137
12.

High-resolution structures of HIV-1 Gag cleavage mutants determine structural switch for virus maturation.

Mattei S, Tan A, Glass B, Müller B, Kräusslich HG, Briggs JAG.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9401-E9410. doi: 10.1073/pnas.1811237115. Epub 2018 Sep 14.

13.

Conductive Polymers: Opportunities and Challenges in Biomedical Applications.

Nezakati T, Seifalian A, Tan A, Seifalian AM.

Chem Rev. 2018 Jul 25;118(14):6766-6843. doi: 10.1021/acs.chemrev.6b00275. Epub 2018 Jul 3.

PMID:
29969244
14.

Cisplatin-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH) with life-threatening hyponatraemia.

Tan AC, Marx GM.

BMJ Case Rep. 2018 Jan 31;2018. pii: bcr-2017-222948. doi: 10.1136/bcr-2017-222948.

PMID:
29386213
15.

Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment.

Shao YM, Ma X, Paira P, Tan A, Herr DR, Lim KL, Ng CH, Venkatesan G, Klotz KN, Federico S, Spalluto G, Cheong SL, Chen YZ, Pastorin G.

PLoS One. 2018 Jan 5;13(1):e0188212. doi: 10.1371/journal.pone.0188212. eCollection 2018.

16.

Nanotechnology for Neuroscience: Promising Approaches for Diagnostics, Therapeutics and Brain Activity Mapping.

Kumar A, Tan A, Wong J, Spagnoli JC, Lam J, Blevins BD, G N, Thorne L, Ashkan K, Xie J, Liu H.

Adv Funct Mater. 2017 Oct 19;27(39). pii: 1700489. doi: 10.1002/adfm.201700489. Epub 2017 Aug 14.

17.

Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer.

Tan AC, Li BT, Nahar K, Danieletto S, Fong ES, Currer T, Parasyn A, Middleton P, Wong H, Smart D, Rutovitz JJ, McCloud P, Hughes TM, Marx GM.

Asia Pac J Clin Oncol. 2018 Apr;14(2):e161-e166. doi: 10.1111/ajco.12779. Epub 2017 Sep 29.

PMID:
28960862
18.

Nanotechnology in neurosurgery: thinking small, dreaming big.

Tan A, Jeyaraj R, Ashkan K.

Br J Neurosurg. 2017 Oct;31(5):538-550. doi: 10.1080/02688697.2017.1327017. Epub 2017 May 24. Review.

PMID:
28537098
19.

Enteral tranexamic acid attenuates vasopressor resistance and changes in α1-adrenergic receptor expression in hemorrhagic shock.

Santamaria MH, Aletti F, Li JB, Tan A, Chang M, Leon J, Schmid-Schönbein GW, Kistler EB.

J Trauma Acute Care Surg. 2017 Aug;83(2):263-270. doi: 10.1097/TA.0000000000001513.

20.

Immune Checkpoint Inhibitors for Brain Metastases.

Tan AC, Heimberger AB, Menzies AM, Pavlakis N, Khasraw M.

Curr Oncol Rep. 2017 Jun;19(6):38. doi: 10.1007/s11912-017-0596-3. Review.

PMID:
28417311

Supplemental Content

Loading ...
Support Center